Abstract A213: Potent anticancer activity <i>in vitro</i> and <i>in vivo</i> by NMS-E973, a novel synthetic inhibitor of HSP90
Gianpaolo Fogliatto, Antonella Isacchi(Nerviano Medical Sciences), Dario Ballinari(Nerviano Medical Sciences), Francesco Colotta(Humanitas University), Mauro Paolucci, Daniele Donati(Nerviano Medical Sciences), Maria Gabriella Brasca(Nerviano Medical Sciences), Carlo Visco(University of Verona), Francesco Sola, Fabio Zuccotto, Marco Guanci(Nerviano Medical Sciences), Elena Casale, Eduard Felder, Sergio Mantegani, Barbara Valsasina(Nerviano Medical Sciences), Paolo Cappella(Nerviano Medical Sciences), Enrico Pesenti, Francesco Caprera(Nerviano Medical Sciences), Juergen Moll(Nerviano Medical Sciences), Anna De Ponti(Nerviano Medical Sciences), Arturo Galvani(Nerviano Medical Sciences), Nadia Amboldi(University of Pavia)
Cited by 0
Related Papers
Discovery of drug mode of action and drug repositioning from transcriptional responses
|Proceedings of the National Academy of Sciences|2010|853